Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Insulet Corp Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

$2.7 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Oct 13, 2021	SELL	$260.36 - $307.27 $474,896 - $560,460	-1,824 Closed	0 $0
Q2 2021 Jul 16, 2021	BUY	$225.52 - $304.06 $411,348 - $554,605	1,824 New	1,824 $501,000

Others Institutions Holding PODD

# of Institutions

612

Shares Held

62.9M

Call Options Held

339K

Put Options Held

916K

Vanguard Group Inc Valley Forge, PA

8.2M
Shares

$1.61 Billion
0.03% of portfolio
Capital Research Global Investors Los Angeles, CA

7.56M
Shares

$1.49 Billion
0.3% of portfolio
Black Rock Inc. New York, NY

6.03M
Shares

$1.19 Billion
0.02% of portfolio
State Street Corp Boston, MA

2.92M
Shares

$575 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

1.99M
Shares

$392 Million
0.06% of portfolio

View Full List

About INSULET CORP

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $13.7B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

More about PODD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Account